MedTech Dive - Latest News

Embecta restructures again, outlines tariff costs

The diabetes tech company announced a second restructuring after ending its insulin patch-pump program.

May 13, 2025 - 20:24
 0
Embecta restructures again, outlines tariff costs

The diabetes tech company announced a second restructuring after ending its insulin patch-pump program.

Read More

Tags:

Previous Article

Rodeo Drive Concours d’Elegance Celebrates 30 Years Of Luxury In Motion

Next Article

Canadian CEO sells Palm Beach County mansion for $50 million

Related Posts

Bausch + Lomb receives CE mark for Luxlife intraocular lens

Bausch + Lomb receives CE mark for Luxlife intraocular ...

May 9, 2025  0

Teal wins FDA approval for at-home cervical cancer screening device

Teal wins FDA approval for at-home cervical cancer scre...

May 13, 2025  0

Masimo finds buyer for consumer audio business

Masimo finds buyer for consumer audio business

May 7, 2025  0